Published in Eur Arch Otorhinolaryngol on September 15, 2010
Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life. Head Neck (2012) 0.91
Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma. Sci Rep (2015) 0.78
An elderly man with an air-fluid level in the middle ear. Malays Fam Physician (2017) 0.75
The effectiveness of myringotomy and ventilation tube insertion versus observation in post-radiation otitis media with effusion. Eur Arch Otorhinolaryngol (2017) 0.75
Nasopharyngeal carcinoma. Lancet (2005) 7.16
Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol (2003) 4.13
Ten-year review of otitis media pathogens. Pediatr Infect Dis J (1992) 2.36
The nasopharynx, eustachian tube and otitis media. J Laryngol Otol (1994) 1.47
Adult-onset otitis media with effusion. Arch Otolaryngol Head Neck Surg (1994) 1.22
Otorrhea after grommet insertion for middle ear effusion in patients with nasopharyngeal carcinoma. Am J Otolaryngol (1999) 0.97
The treatment for postirradiation otitis media with effusion: a study of three methods. Laryngoscope (2008) 0.94
The otological status of patients with nasopharyngeal carcinoma after megavoltage radiotherapy. J Laryngol Otol (1992) 0.88
Computed tomography, magnetic resonance imaging, and electromyographic studies of tensor veli palatini muscles in patients with nasopharyngeal carcinoma. Laryngoscope (1993) 0.85
A 10-year longitudinal study of tubal function in patients with nasopharyngeal carcinoma after irradiation. Arch Otolaryngol Head Neck Surg (1997) 0.84
Eustachian tube function of patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol (1995) 0.83
Failure of grommet insertion in post-irradiation otitis media with effusion. Ann Otol Rhinol Laryngol (2001) 0.81
A prospective study of otitis media with effusion in adults and children. Clin Otolaryngol Allied Sci (1992) 0.81
Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma. Head Neck (2003) 0.80
Bacteriology of otitis media with effusion. J Laryngol Otol (1989) 0.79
Nasopharyngeal carcinoma and middle ear effusion: natural history and the effect of ventilation tubes. Clin Otolaryngol Allied Sci (1994) 0.79
Mechanism of hearing loss in irradiated ears: a long-term longitudinal study. Ann Otol Rhinol Laryngol (2001) 0.79
Analysis of anatomical factors controlling the morbidity of radiation-induced otitis media with effusion. Radiother Oncol (2007) 0.77
The efficacy of myringotomy and ventilation tube insertion in middle-ear effusions in patients with nasopharyngeal carcinoma. Laryngoscope (1987) 0.77
Effects of irradiation on the rat middle ear mucosa. A scanning electron microscopic study. Eur Arch Otorhinolaryngol (1995) 0.75
Ventilation tube in adults with middle-ear effusion. J Otolaryngol (1999) 0.75
Serous otitis media and paranasopharyngeal extension of nasopharyngeal carcinoma. Head Neck (1992) 0.75
Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol (2003) 4.13
Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med (2004) 3.19
Acute respiratory distress syndrome in scrub typhus. Am J Trop Med Hyg (2007) 2.48
Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation (2010) 2.38
Relationship between overnight rostral fluid shift and Obstructive Sleep Apnea in nonobese men. Am J Respir Crit Care Med (2008) 2.29
Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res (2004) 2.01
Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci (2005) 1.97
Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer. Gynecol Oncol (2011) 1.57
Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.48
Visual screening of oral cavity cancer in a male population: experience from a medical center. J Chin Med Assoc (2011) 1.43
Comparison of the skin test and ImmunoCAP system in the evaluation of mold allergy. J Chin Med Assoc (2006) 1.39
Differences in clinical and laboratory characteristics and disease severity between children and adults with dengue virus infection in Taiwan, 2002. Trans R Soc Trop Med Hyg (2009) 1.33
Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.21
Another way to estimate outcome of advanced nasopharyngeal carcinoma--is concurrent chemoradiotherapy adequate? Int J Radiat Oncol Biol Phys (2004) 1.20
Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels. Cancer (2012) 1.19
Laryngeal tuberculosis: a review of 26 cases. Otolaryngol Head Neck Surg (2007) 1.18
Olfactory function in patients with chronic rhinosinusitis before and after functional endoscopic sinus surgery. Am J Rhinol (2008) 1.18
Nutritional factors and survival of patients with oral cancer. Head Neck (2006) 1.17
Hearing loss associated with enlarged vestibular aqueduct and Mondini dysplasia is caused by splice-site mutation in the PDS gene. Hear Res (2005) 1.17
Plasma EBV DNA clearance rate as a novel prognostic marker for metastatic/recurrent nasopharyngeal carcinoma. Clin Cancer Res (2010) 1.13
Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.11
Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo-controlled, double-blind study. Am J Rhinol (2008) 1.09
Smoking, alcohol, and betel quid and oral cancer: a prospective cohort study. J Oncol (2011) 1.06
Evaluation of genotoxic risk and oxidative DNA damage in mammalian cells exposed to mycotoxins, patulin and citrinin. Toxicol Appl Pharmacol (2003) 1.03
Socio-demographic factors in the prognosis of oral cancer patients. Oral Oncol (2006) 1.02
Mutations of Cx26 gene (GJB2) for prelingual deafness in Taiwan. Eur J Hum Genet (2002) 1.01
Preoperative prognostic factors for olfactory change after functional endoscopic sinus surgery. Am J Rhinol Allergy (2009) 1.00
A pilot study of a traditional Chinese version of the University of Pennsylvania Smell Identification Test for application in Taiwan. Am J Rhinol Allergy (2010) 0.98
Identification of novel mutations in the KCNQ4 gene of patients with nonsyndromic deafness from Taiwan. Audiol Neurootol (2006) 0.96
Prognostic factors in patients with buccal squamous cell carcinoma: 10-year experience. J Oral Maxillofac Surg (2011) 0.96
Somatic mutations in the D-loop of mitochondrial DNA in oral squamous cell carcinoma. Eur Arch Otorhinolaryngol (2011) 0.96
The diagnosis of sinonasal lymphoma: a challenge for rhinologists. Eur Arch Otorhinolaryngol (2011) 0.95
Comparison between free flap and pectoralis major pedicled flap for reconstruction in oral cavity cancer patients--a quality of life analysis. Oral Oncol (2011) 0.95
Experience of cancer care for metastasis-induced acute pancreatitis patients with lung cancer. J Thorac Oncol (2009) 0.95
Induction of apoptosis by high-dose gold nanoparticles in nasopharyngeal carcinoma cells. Auris Nasus Larynx (2013) 0.94
Impact of pulsatile nasal irrigation on the prognosis of functional endoscopic sinus surgery. J Otolaryngol Head Neck Surg (2008) 0.94
Somatic mutations of mitochondrial genome in hepatocellular carcinoma. Mitochondrion (2009) 0.93
Survival analysis of patients with oral squamous cell carcinoma with simultaneous second primary tumors. Head Neck (2013) 0.93
Castleman's disease of the neck. J Chin Med Assoc (2007) 0.92
Consistent sequence variation of Epstein-Barr virus nuclear antigen 1 in primary tumor and peripheral blood cells of patients with nasopharyngeal carcinoma. Clin Cancer Res (2002) 0.91
Differential impact of IL-10 expression on survival and relapse between HPV16-positive and -negative oral squamous cell carcinomas. PLoS One (2012) 0.90
The basis of preoperative vocal fold paralysis in a series of patients undergoing thyroid surgery: the preponderance of benign thyroid disease. Thyroid (2011) 0.88
Assessment of salivary function change in nasopharyngeal carcinoma treated by parotid-sparing radiotherapy. Cancer J (2007) 0.87
Carotid blowout in patients with head and neck cancer: associated factors and treatment outcomes. Head Neck (2014) 0.87
Effects of KRAS mutation and polymorphism on the risk and prognosis of oral squamous cell carcinoma. Head Neck (2011) 0.87
A novel missense mutation in the connexin30 causes nonsyndromic hearing loss. PLoS One (2011) 0.86
Traditional Chinese Medicine ZHENG Identification Provides a Novel Stratification Approach in Patients with Allergic Rhinitis. Evid Based Complement Alternat Med (2012) 0.86
Impact of recurrence interval on survival of oral cavity squamous cell carcinoma patients after local relapse. Otolaryngol Head Neck Surg (2007) 0.85
Peripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapy. PLoS One (2013) 0.85
Measurements of normal inner ear on computed tomography in children with congenital sensorineural hearing loss. Eur Arch Otorhinolaryngol (2009) 0.85
Chest radiographic presentation in patients with scrub typhus. Trans R Soc Trop Med Hyg (2011) 0.85
Chest radiographic presentation in patients with dengue hemorrhagic Fever. Am J Trop Med Hyg (2007) 0.85
Nasal irrigation reduces postirradiation rhinosinusitis in patients with nasopharyngeal carcinoma. Am J Rhinol (2008) 0.85
Long-term results of intensity-modulated radiotherapy concomitant with chemotherapy for hypopharyngeal carcinoma aimed at laryngeal preservation. BMC Cancer (2010) 0.84
Identification of novel variants in the TMIE gene of patients with nonsyndromic hearing loss. Int J Pediatr Otorhinolaryngol (2010) 0.84
Shrinkage of head and neck cancer specimens after formalin fixation. J Chin Med Assoc (2012) 0.84
Evaluation of citrinin occurrence and cytotoxicity in Monascus fermentation products. J Agric Food Chem (2005) 0.84
Association of p53 codon 72 polymorphism with risk of hypopharyngeal squamous cell carcinoma in Taiwan. J Formos Med Assoc (2006) 0.83
Laryngeal electromyography-guided hyaluronic acid vocal fold injection for unilateral vocal fold paralysis--preliminary results. J Voice (2011) 0.83
Mortality risk factors in patients with Acinetobacter baumannii ventilator: associated pneumonia. J Formos Med Assoc (2011) 0.82
Nasopharyngeal carcinoma during pregnancy. Taiwan J Obstet Gynecol (2007) 0.82
Mutation R184Q of connexin 26 in hearing loss patients has a dominant-negative effect on connexin 26 and connexin 30. Eur J Hum Genet (2010) 0.81
Nasal mycology of chronic rhinosinusitis. Am J Rhinol (2005) 0.81
Tailor-made zinc-finger transcription factors activate FLO11 gene expression with phenotypic consequences in the yeast Saccharomyces cerevisiae. PLoS One (2007) 0.81
Familial tendency and risk of nasopharyngeal carcinoma in taiwan: effects of covariates on risk. Am J Epidemiol (2010) 0.81
Isolated osteoradionecrosis of the dens mimicking metastasis of nasopharyngeal carcinoma after radiotherapy. J Clin Neurosci (2010) 0.81
Il13 promoter (-1055) polymorphisms associated with chronic obstructive pulmonary disease in Taiwanese. Exp Lung Res (2009) 0.81
Developing a rabbit model of rhinogenic chronic rhinosinusitis. Laryngoscope (2008) 0.81
The volume of retropharyngeal nodes predicts distant metastasis in patients with advanced nasopharyngeal carcinoma. Oral Oncol (2011) 0.80
From NPC therapeutic target identification to potential treatment strategy. Mol Cancer Ther (2010) 0.80
A novel p53 mutant retained functional activity in lung carcinomas. DNA Repair (Amst) (2002) 0.80
Validation of the applicability of the traditional Chinese version of the University of Pennsylvania Smell Identification Test in patients with chronic rhinosinusitis. Allergy Rhinol (Providence) (2014) 0.80
Bacteriology of acute rhinosinusitis in nasopharyngeal carcinoma survivors: a result of maxillary sinus punctures. Eur Arch Otorhinolaryngol (2007) 0.80